Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illuminas Updated Comprehensive Gene Panel Assay, TruSight Oncology 500 v2
Agreement will expand worldwide access and better position Myriad’s GIS as a…